Skip to content
HowShorted

Cardiff Oncology, Inc. short interest in 2023

In 2023, Cardiff Oncology, Inc.'s disclosed short interest ran from 2.24% of shares outstanding on 13 Jan 2023 to 2.95% on 29 Dec 2023, a change of +0.71 percentage points. The year's high was 3.64% on 31 Oct 2023 and its low 1.10% on 14 Jul 2023, averaging 1.93% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.11 days on 30 Nov 2023. Full history: Cardiff Oncology, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cardiff Oncology, Inc. in 2023

2023 in figures

Start of year
2.24% (13 Jan 2023)
End of year
2.95% (29 Dec 2023)
Change
+0.71 pp
High
3.64% (31 Oct 2023)
Low
1.10% (14 Jul 2023)
Average
1.93%
Highest days to cover
11.11 (30 Nov 2023)
SEC filings marked
8

Every report in 2023

Cardiff Oncology, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20232.24%4.16
31 Jan 20232.03%3.07
15 Feb 20231.79%2.93
28 Feb 20231.53%4.09
15 Mar 20231.51%2.8310-K filed, results (8-K)
31 Mar 20231.40%2.49
14 Apr 20231.41%3.57
28 Apr 20231.38%3.57
15 May 20231.21%2.7710-Q filed, results (8-K)
31 May 20231.21%4.70
15 Jun 20231.19%4.66
30 Jun 20231.20%3.08
14 Jul 20231.10%3.60
31 Jul 20231.16%3.03
15 Aug 20231.49%1.0010-Q filed, results (8-K)
31 Aug 20231.20%3.62
15 Sep 20231.51%3.31
13 Oct 20233.42%3.26
31 Oct 20233.64%6.51
15 Nov 20233.57%6.3210-Q filed, results (8-K)
30 Nov 20233.24%11.11
15 Dec 20233.02%9.81
29 Dec 20232.95%7.86

See also: Cardiff Oncology, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.